Preoperative transarterial chemoembolization for laparoscopic liver resection in Child A cirrhotic patients with hepatocellular carcinoma

被引:9
|
作者
Lopez-Lopez, Victor [1 ]
Brusadin, Roberto [1 ]
Lopez-Conesa, Asuncion [1 ]
Capel, Antonio [2 ]
Navarro-Barrios, Alvaro [1 ]
Cayuela, Valentin [1 ]
Lopez-Banet, Elena [3 ]
Garzon-Arana, Alejandro [4 ]
Parrilla-Paricio, Pascual [1 ]
Robles-Campos, Ricardo [1 ]
机构
[1] IMIB ARRIXACA, Clin & Univ Hosp Virgen de la Arrixaca, Dept Gen Visceral & Transplantat Surg, Murcia, Spain
[2] IMIB, Virgen de la Arrixaca Clin & Univ Hosp, Dept Intervent Radiol, Murcia, Spain
[3] IMIB, Virgen de la Arrixaca Clin & Univ Hosp, Dept Radiol, Murcia, Spain
[4] IMIB, Virgen de la Arrixaca Clin & Univ Hosp, Dept Surg Pathol, Murcia, Spain
关键词
Transarterial chemoembolization; Hepatocellular carcinoma; Laparoscopy; Liver resection; HEPATIC RESECTION; LONG-TERM; METAANALYSIS; OUTCOMES;
D O I
10.1007/s00423-020-02056-x
中图分类号
R61 [外科手术学];
学科分类号
摘要
Purpose Laparoscopic liver resection (LLR) for hepatocellular carcinoma (HCC) offers better short-term results than open surgery with similar long-term results although it is technically difficult due to the risk of bleeding. Methods This study included patients with HCC in Child A cirrhosis who underwent TACE before LLR between 2009 and 2019. The primary endpoint was to analyze the intraoperative and early results of this technique. We also analyzed the long-term outcomes. Patients with and without clinically significant portal hypertension (CSPH) were compared. Results A total of 44 cirrhotic patients with HCC were included (24 CSPH and 20 non-CSPH). The Pringle maneuver was used in two cases (4.5%), mean blood losses was 100 ml (range 50-200), and three patients (6.8%) required a blood transfusion. The degree of necrosis achieved was greater than 90% in 27 patients (61.4%). At 1, 3, and 5 years, overall survival was 97.7%, 81.5%, and 63.4%, respectively, and disease-free survival was 85.2%, 52.5%, and 34.5%, respectively. There were no statistically significant differences between non-CSPH and CSPH groups regarding intraoperative, early, and long-term outcomes. Conclusion In our experience, TACE could be beneficial to perform LLR in HCC Child-Pugh A patients with and without CSPH without serious complications and similar oncological outcomes.
引用
收藏
页码:763 / 771
页数:9
相关论文
共 50 条
  • [41] Prognostic value of preoperative serum ferritin in hepatocellular carcinoma patients undergoing transarterial chemoembolization
    Fan, Mi
    Niu, Tingting
    Lin, Binwei
    Gao, Feng
    Tan, Bangxian
    Du, Xiaobo
    MOLECULAR AND CLINICAL ONCOLOGY, 2024, 20 (03)
  • [42] Transarterial chemoembolization of hepatocellular carcinoma
    Huppert, Peter
    RADIOLOGE, 2022, 62 (03): : 225 - 233
  • [43] Transarterial chemoembolization of hepatocellular carcinoma
    Huppert, Peter
    RADIOLOGIE, 2022, 62 (03): : 225 - 233
  • [44] Laparoscopic liver resection for hepatocellular carcinoma in cirrhotic patients. Feasibility of nonanatomic resection in difficult tumor locations
    Casaccia, Marco
    Andorno, Enzo
    Di Domenico, Stefano
    Nardi, Ilaria
    Bottino, Giuliano
    Gelli, Maximiliano
    Valente, Umberto
    JOURNAL OF MINIMAL ACCESS SURGERY, 2011, 7 (04) : 222 - 226
  • [45] Transarterial chemoembolization for hepatocellular carcinoma
    Lau, WY
    Yu, SCH
    Lai, ECH
    Leung, TWT
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2006, 202 (01) : 155 - 168
  • [46] TRANSARTERIAL CHEMOEMBOLIZATION FOR HEPATOCELLULAR CARCINOMA
    Vremera, Teodora
    MEDICAL-SURGICAL JOURNAL-REVISTA MEDICO-CHIRURGICALA, 2013, 117 (01): : 182 - 182
  • [47] The effect of adjuvant transarterial chemoembolization for hepatocellular carcinoma after liver resection based on risk stratification
    Jin-Shu Zeng
    Jian-Xing Zeng
    Yao Huang
    Jing-Feng Liu
    Jin-Hua Zeng
    Hepatobiliary&PancreaticDiseasesInternational, 2023, 22 (05) : 482 - 489
  • [48] The effect of adjuvant transarterial chemoembolization for hepatocellular carcinoma after liver resection based on risk stratification
    Zeng, Jin-Shu
    Zeng, Jian-Xing
    Huang, Yao
    Liu, Jing-Feng
    Zeng, Jin-Hua
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2023, 22 (05) : 482 - 489
  • [49] Liver resection versus transarterial chemoembolization for huge hepatocellular carcinoma: a propensity score matched analysis
    Bogdanovic, A.
    Bulajic, P.
    Masulovic, D.
    Bidzic, N.
    Zivanovic, M.
    Galun, D.
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [50] Liver resection versus transarterial chemoembolization for huge hepatocellular carcinoma: a propensity score matched analysis
    A. Bogdanovic
    P. Bulajic
    D. Masulovic
    N. Bidzic
    M. Zivanovic
    D. Galun
    Scientific Reports, 11